Publication date: 02/01/2019
In the coming week, eTheRNA immunotherapies will participate in the Biotech Showcase as well as in the China Focus event, both organized in parallel to the 37th Annual J.P. Morgan Healthcare Conference in San Francisco (CA, USA).
Steven Powell, CEO eTheRNA immunotherapies (photo), will present the company’s mRNA platform and its clinical development program at the Biotech Showcase on Monday, January 7 at 11:45 A.M. (local time) in Hilton Hotel at the San Francisco Union Square in San Francisco (CA, USA). More information: https://ebdgroup.knect365.com/biotech-showcase/
At the China Focus event, Steven Powell’s presentation slots are on Sunday, January 6th at 9:55 A.M. and at 1.30 P.M. (local time) in JW Mariott SF hotel, Union Square 515 Mason St. (room 201). More information: https://events.mybiogate.com/jpmweek/
About eTheRNA immunotherapies eTheRNA immunotherapies is a clinical-stage Belgian biotech company applying mRNA based immunotherapies to the treatment of cancer. eTheRNA’s goal is to commercialize these immunotherapies to deliver long lasting clinical remission to cancer patients. More information at www.etherna.be